While a wide range of pharmacological treatments and disease management regimens exist to treat these conditions with varying degrees of efficacy, a promising new drug class known as glucagon-like peptide 1 receptor agonists (GLP-1s) and combination incretins such as dual GLP-1/glucosedependent insulinotropic polypeptides (GLP-1/GIPs, a subcategory of GLP-1s) has attracted widespread attention and interest from providers and patients for its potential to treat both these and adjacent conditions, and especially to drive weight loss
Pani MA, Regulla K, Segni M, Hofmann S, Hufner M, Pasquino AM, Usadel KH, Badenhoop K
The antioxidant defense system is a large network of molecules which eliminate free radicals and production of ROS [18, 19]
I also have experience working with clients and family members, helping them decide which vitamins to buy to best suit their needs